OsteoBor for postmenopausal osteoporosis
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This trial tests a boron-based supplement called OsteoBor to see if it helps strengthen bones in postmenopausal women who have osteoporosis (low bone density). You would take OsteoBor or a placebo daily along with calcium and vitamin D.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 45 to 85 who has gone through menopause (no period for at least 1 year).
- Your bone density test shows a T-score between -2.5 and -3.5 (osteoporosis but not too severe).
- You are generally healthy with no major chronic illnesses that affect bones or your ability to follow the study.
- You are willing to take OsteoBor or a placebo pill every day along with calcium and vitamin D supplements.
- You have not had a hip fracture or more than one spinal fracture ever, and no other broken bones (except fingers, toes, or skull) in the last 2 years.
- You have not taken certain osteoporosis medications like bisphosphonates, denosumab, teriparatide, or steroids in the past 6 to 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well your blood vessels work and how strong your muscles are, in women after menopause with osteoporosis. You may be asked to start standard osteoporosis treatment, and the researchers will study pain and changes related to vascular function and sarcopenia (loss of muscle and strength).
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study looks at what changes in the body after starting romosozumab (an osteoporosis treatment) in postmenopausal women at higher risk for fractures. Researchers want to understand the treatment’s “mechanism,” which may help improve future osteoporosis care.
This trial looks at how well women with postmenopausal osteoporosis follow their treatment plan, which includes a bisphosphonate taken once a week or once a month along with daily calcium and vitamin D supplements. The goal is to understand patterns that may help improve care.
This trial looks at how exercise, alone or with osteoporosis medication, affects bone health in women after menopause. It may help you find a safe way to strengthen your bones.
This study tests a new form of calcium (amorphous calcium carbonate) to see if it can improve bone density in postmenopausal women with osteoporosis. It may offer an alternative for women who cannot or choose not to take other osteoporosis medications.
Hear when a new Osteoporosis, Postmenopausal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.